3-123448117-AGCCGCCGCCGCCGAGCCGCC-AGCC

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_183357.3(ADCY5):​c.412_428delGGCTCGGCGGCGGCGGC​(p.Gly138CysfsTer184) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000316 in 948,280 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.0 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000032 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

ADCY5
NM_183357.3 frameshift

Scores

Not classified

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 1.90

Publications

0 publications found
Variant links:
Genes affected
ADCY5 (HGNC:236): (adenylate cyclase 5) This gene encodes a member of the membrane-bound adenylyl cyclase enzymes. Adenylyl cyclases mediate G protein-coupled receptor signaling through the synthesis of the second messenger cAMP. Activity of the encoded protein is stimulated by the Gs alpha subunit of G protein-coupled receptors and is inhibited by protein kinase A, calcium and Gi alpha subunits. Single nucleotide polymorphisms in this gene may be associated with low birth weight and type 2 diabetes. Alternatively spliced transcript variants that encode different isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
ADCY5 Gene-Disease associations (from GenCC):
  • dyskinesia with orofacial involvement, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • neurodevelopmental disorder with hyperkinetic movements and dyskinesia
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial dyskinesia and facial myokymia
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • choreatic disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 3-123448117-AGCCGCCGCCGCCGAGCC-A is Pathogenic according to our data. Variant chr3-123448117-AGCCGCCGCCGCCGAGCC-A is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 817996.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADCY5NM_183357.3 linkc.412_428delGGCTCGGCGGCGGCGGC p.Gly138CysfsTer184 frameshift_variant Exon 1 of 21 ENST00000462833.6 NP_899200.1
ADCY5NM_001378259.1 linkc.412_428delGGCTCGGCGGCGGCGGC p.Gly138CysfsTer184 frameshift_variant Exon 1 of 22 NP_001365188.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADCY5ENST00000462833.6 linkc.412_428delGGCTCGGCGGCGGCGGC p.Gly138CysfsTer184 frameshift_variant Exon 1 of 21 1 NM_183357.3 ENSP00000419361.1
ADCY5ENST00000850916.1 linkc.574_590delGGCTCGGCGGCGGCGGC p.Gly192CysfsTer184 frameshift_variant Exon 1 of 21 ENSP00000520999.1
ADCY5ENST00000699718.1 linkc.412_428delGGCTCGGCGGCGGCGGC p.Gly138CysfsTer184 frameshift_variant Exon 1 of 22 ENSP00000514543.1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
146220
Hom.:
0
Cov.:
32
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000316
AC:
3
AN:
948280
Hom.:
0
AF XY:
0.00000444
AC XY:
2
AN XY:
449958
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
18244
American (AMR)
AF:
0.00
AC:
0
AN:
4288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8572
East Asian (EAS)
AF:
0.00
AC:
0
AN:
11230
South Asian (SAS)
AF:
0.00
AC:
0
AN:
19926
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
11212
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2176
European-Non Finnish (NFE)
AF:
0.00000358
AC:
3
AN:
838644
Other (OTH)
AF:
0.00
AC:
0
AN:
33988
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000395253), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.258
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
146220
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
71126
African (AFR)
AF:
0.00
AC:
0
AN:
40598
American (AMR)
AF:
0.00
AC:
0
AN:
14750
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5052
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8564
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
65858
Other (OTH)
AF:
0.00
AC:
0
AN:
2024

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Jan 24, 2019
GeneDx
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.412_428del17 variant in the ADCY5 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant causes a frameshift starting with codon Glycine 138, changes this amino acid to a Cysteine residue, and creates a premature Stop codon at position 184 of the new reading frame, denoted p.Gly138CysfsX184. The c.412_428del17 variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. This variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.412_428del17 as a likely pathogenic variant. -

Neurodevelopmental disorder with hyperkinetic movements and dyskinesia Pathogenic:1
Sep 29, 2022
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has not been reported in literature. However, truncating variants lying in the downstream of the identified variants have been reported as pathogenic in the context of dyskinesia with orofacial involvement, autosomal dominant/recessive in the ClinVar database. Loss-of-function variants in the ADCY5 gene are known to be pathogenic [PMID: 28971144, 34631954]. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.9
Mutation Taster
=39/161
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1553751262; hg19: chr3-123166964; API